Screening Tests
Screening Tests
Many cancer screening tests are in use, some tests have been shown to reduce the chances of detecting cancer and dying of disease. Others have been shown to detect cancer but have not been shown to reduce the risk of cancer death; However, they can still be introduced to people, especially those who are known to increase the risk of cancer.
On this page
Screening test shown to reduce cancer death
Coaloscopy, sigmodoscopy, and secret blood test (FOBT) of the membrane with high sensitivity
These tests have been shown to reduce the deaths of colorectal cancer. Colonoscopy and sigmoidoscopy also help to prevent colorectal cancer because they can detect abnormal colon growth (polyps) which can be removed before they develop in cancer. Expert groups generally recommend that those who are average risk for colorectal cancer are screening at the age of 50 to 75 years. For more information, see Test for the Detection of Colorectal Cancer and Polyps Fact Sheet and PDKA Colorectal Cancer Screening Summary.
Low dose helical calculation tomography
To test lung cancer, this test has been shown to reduce lung cancer deaths among smokers aged 55 to 74. For more information, see National Lung Screening Trial Page and PDQX-Lung Cancer Screening Summary.
Mammography
To check for breast cancer, this method is shown to reduce the mortality rate from 40 to 74 years of age, especially for the age of 50 years or more, for more information, mammogram facts sheet and PDK-1-breast cancer screening summary view.
Pap test and human papillomavirus (HPV) test
These tests reduce the incidence of cervical cancer because they allow abnormal cells to be identified and treated before being cancerous. They also reduce death from cervical cancer. Normally the test is recommended starting from the age of 21 and ending at the age of 65, as long as the recent results are normal. For more information, see Pap and HPV test fact sheet and PDQqualicy cancer screening summary.
Other Screening Tests
Alpha -phiaproteine blood test
This test is sometimes used to detect liver cancer at the onset of high-risk people, along with liver ultrasound. For more information, see PDQ® Liver Cancer (Hepotocellular) Cancer Screening Summary.
Breast MRI
This imaging test is often used for women who do harmful mutations in the BRCA1 genes or BRCA2 genes; Such women have a greater risk of breast cancer, as well as increased risk for other cancers. For more information, see BRCA1 and BRCA2: Cancer Risk and Genetic Testing Fact Sheet and PDKAI Breast Cancer Screening Summary.
Many cancer screening tests are in use, some tests have been shown to reduce the chances of detecting cancer and dying of disease. Others have been shown to detect cancer but have not been shown to reduce the risk of cancer death; However, they can still be introduced to people, especially those who are known to increase the risk of cancer.
On this page
- Screening test shown to reduce cancer death
- Other Screening Tests
- more information
Screening test shown to reduce cancer death
Coaloscopy, sigmodoscopy, and secret blood test (FOBT) of the membrane with high sensitivity
These tests have been shown to reduce the deaths of colorectal cancer. Colonoscopy and sigmoidoscopy also help to prevent colorectal cancer because they can detect abnormal colon growth (polyps) which can be removed before they develop in cancer. Expert groups generally recommend that those who are average risk for colorectal cancer are screening at the age of 50 to 75 years. For more information, see Test for the Detection of Colorectal Cancer and Polyps Fact Sheet and PDKA Colorectal Cancer Screening Summary.
Low dose helical calculation tomography
To test lung cancer, this test has been shown to reduce lung cancer deaths among smokers aged 55 to 74. For more information, see National Lung Screening Trial Page and PDQX-Lung Cancer Screening Summary.
Mammography
To check for breast cancer, this method is shown to reduce the mortality rate from 40 to 74 years of age, especially for the age of 50 years or more, for more information, mammogram facts sheet and PDK-1-breast cancer screening summary view.
Pap test and human papillomavirus (HPV) test
These tests reduce the incidence of cervical cancer because they allow abnormal cells to be identified and treated before being cancerous. They also reduce death from cervical cancer. Normally the test is recommended starting from the age of 21 and ending at the age of 65, as long as the recent results are normal. For more information, see Pap and HPV test fact sheet and PDQqualicy cancer screening summary.
Other Screening Tests
Alpha -phiaproteine blood test
This test is sometimes used to detect liver cancer at the onset of high-risk people, along with liver ultrasound. For more information, see PDQ® Liver Cancer (Hepotocellular) Cancer Screening Summary.
Breast MRI
This imaging test is often used for women who do harmful mutations in the BRCA1 genes or BRCA2 genes; Such women have a greater risk of breast cancer, as well as increased risk for other cancers. For more information, see BRCA1 and BRCA2: Cancer Risk and Genetic Testing Fact Sheet and PDKAI Breast Cancer Screening Summary.
CA125 test
This blood test, which is often done with the Ernantswag ultrasound, can be used especially for women to detect ovarian cancer, which is accompanied by increased risk of disease. Although this test can help in diagnosing ovarian cancer in women who have symptoms and can be used to evaluate the recurrence of cancer in women before diagnosis of disease, it is not an effective ovarian cancer screening test. have been shown. See PDK Ovarian Cancer Screening Summary for more
Information.
Clinical breast examination and regular breast self-examination
Breast cancer has not been tested regularly by health care providers or women to reduce the deaths of breast cancer. However if a woman or her health care provider informs a lump or other abnormal changes in the breast then it is important to check it out for more information see PDQ breast cancer screening summary.
Psa test
This blood test that is often done with a digital rational examination is able to detect prostate cancer in the early stages. Although specialist groups do not now recommend regular PSA tests for most men because studies have shown that there is little or no effect on prostate cancer deaths and leads to overdignosis and overtact. For more information see Prostate-Specific Antigen (PSA) Test Fact Sheet and PDK Prostate Cancer Screening Summary.
Skin examination
Doctors often recommend that those who are at risk of skin cancer regularly check their skin or are health care providers. Such tests have not been shown to reduce the risk of dying of skin cancer and they can be over-consumed. Although people should be aware of changes in their skin such as changes in a new mole or existing sesame, and report them to your doctor immediately. For more information see Common Moles, Disclosure Navy and Melanoma Fact Sheet Risks and Brain Skin Cancer Screening Summary
Transvaginal ultrasound
This imaging test, which can make a woman's ovaries and uterus, sometimes raises the risk of ovarian cancer in women (because they take a harmful BRCA1 or BRCA2 mutation) or cause endometrial cancer They are called lynch syndrome but this cancer is not shown to reduce death. For more information, see PDK Ovarian Cancer Screening Summary and PDU Endometrial Cancer Screening Summary.
Virtual colonoscopy
This test allows the examination of the colon and rectum from the body outside, however, it is too late. For more information, see the test to find colorectal cancer and polyps fact sheet and medal colorectal cancer screening summary.
More information
Cancer information summary: screening detection test for cancer.
No comments